Figure 2.
Survival benefit of IMRT over 3D-CRT in early-stage NKTCL. OS and PFS after IMRT or 3D-CRT for the entire cohort (A-B) and for the PSM cohort (C-D).

Survival benefit of IMRT over 3D-CRT in early-stage NKTCL. OS and PFS after IMRT or 3D-CRT for the entire cohort (A-B) and for the PSM cohort (C-D).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal